Use of peptide library screening to detect a previously unknown linear diagnostic epitope: Proof of principle by use of Lyme disease sera

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 7, 2005, Pages 801-807

  Hamby, Carl V ^a   Llibre, Marta ^a   Utpat, Sandeepa ^a   Wormser, Gary P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EPITOPE; LYSYLALANYLALANYLSERYLLYSYLGLUTAMYLTHREONYLPROLYLPROLYLALANYLLEUCYLASPARAGI NYLLYSINE; PEPTIDE LIBRARY; PROTEIN BBA61; PROTEIN VLSE; SERYLLYSYLGLUTAMYLLYSYLPROLYLSERYLLEUCYLASPARAGINYLTRYPTOPHYLPROLYLALANINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; BACTERIOPHAGE; BORRELIA BURGDORFERI; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; HYPOTHESIS; IMMUNOREACTIVITY; LYME DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN MOTIF; REPRODUCIBILITY; SCREENING; SENSITIVITY ANALYSIS; SERUM;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORRELIA BURGDORFERI; EPITOPES; HUMANS; LYME DISEASE; PEPTIDE LIBRARY; PEPTIDES; SENSITIVITY AND SPECIFICITY;

EID: 22244481253     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.7.801-807.2005     Document Type: Article

References (19)

1. Adda, C. G., R. F. Anders, L. Tilley, and M. Foley. 2002. Random sequence libraries displayed on phage: identification of biologically important molecules. Comb. Chem. High Throughput Screen. 5:1-14.
2. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, Jr., M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. B. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VIsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
3. Cortese, I., R. Tafi, L. M. Grimaldi, G. Martino, A. Nicosia, and R. Cortese. 1996. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA 93: 11063-11067.
4. Cortese, R., F. Felici, G. Galfre, A. Luzzago, P. Monaci, and A. Nicosia. 1994. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol. 12:262-267.
5. Eicken, C., V. Sharma, T. Klabunde, M. B. Lawrenz, J. M. Hardham, S. J. Norris, and J. C. Sacchettini. 2002. Crystal structure of Lyme disease variable surface antigen VIsE of Borrelia burgdorferi. J. Biol. Chem. 277:21691-21696.
6. Folgori, A., R. Tafi, A. Meola, F. Felici, G. Galfre, R. Cortese, P. Monaci, and A. Nicosia. 1994. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13:2236-2243.
7. Gilmore, R. D., Jr., K. J. Kappel, and B. J. B. Johnson. 1997. Molecular characterization of a 35-kilodalton protein of Borrelia burgdorferi, an antigen of diagnostic importance in early Lyme disease. J. Clin. Microbiol. 35:86-91.
8. Iniguez, P., S. Zientara, M. Marault, I. B. Machin, D. Hannant, and C. Cruciere. 1998. Screening of horse polyclonal antibodies with a random peptide library displayed on phage: identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus. J. Virol. Methods 73:175-183.
9. Irving, M. B., O. Pan, and J. K. Scott. 2001. Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr. Opin. Chem. Biol. 5:314-324.
10. Kouzmitcheva, G. A., V. A. Petrenko, and G. P. Smith. 2001. Identifying diagnostic peptides for Lyme disease through epitope discovery. Clin. Diagn. Lab. Immunol. 8:150-160.
11. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VIsE. J. Clin. Microbiol. 37:3990-3996.
12. Liang, F. T., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. 1999. An immunodominant conserved region within the variable domain of VIsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol. 163:5566-5573.
13. Liang, F. T., L. C. Bowers, and M. T. Philipp. 2001. C-terminal invariable domain of VIsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect. Immun. 69:3224-3231.
14. Motti, C., M. Nuzzo, A. Meola, G. Galfre, F. Felici, R. Cortese, A. Nicosia, and P. Monaci. 1994. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 146: 191-198.
15. 6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187:1178-1186.
16. Santamaria, H., K. Manoutcharian, L. Rocha, E. Gonzalez, G. Acero, T. Govezensky, L. I. Uribe, A. Olguin, J. Paniagua, and G. Gevorkian. 2001. Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries. Clin. Immunol. 101:296-302.
17. Smith, G. P., and V. A. Petrenko. 1997. Phage display. Chem. Rev. 97:391-410.
18. Yu, Z., J. M. Carter, S. Y. Huang, H. Lackland, L. H. Sigal, and S. Stein. 1996. Presentation of peptide antigens as albumin conjugates for use in detection of serum antibodies by enzyme-linked immunosorbent assay. Bioconjug. Chem. 7:338-342.
19. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.